4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-23-034931
Chief Medical Officer bought 595,425 shares at an average $0.32 ($188,737)
From the SEC's structured data for this filing
Trades in this filing
Puhlmann Markus · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-15 | Purchase : show line 1 in the form | +135,006 | $0.27 | $36,276 | 635,006 | D |
| 2023-12-18 | Purchase : show line 2 in the form | +60,419 | $0.26 | $15,461 | 695,425 | D |
| 2023-12-19 | Purchase : show line 3 in the form | +400,000 | $0.34 | $137,000 | 1,095,425 | D |
| Open-market purchases · 595,425 sh · avg $0.32 · $188,737 | ||||||
Loading xslF345X05/rdgdoc.xml…